Raymond James Financial’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1M Buy
224,875
+12,682
+6% +$1.62M 0.01% 1232
2025
Q4
$25.5M Buy
212,193
+16,119
+8% +$1.93M 0.01% 1271
2025
Q3
$23.4M Buy
196,074
+1,345
+0.7% +$158K 0.01% 1304
2025
Q2
$22M Sell
194,729
-1,078
-0.6% -$115K 0.01% 1299
2025
Q1
$20.2M Sell
195,807
-2,086
-1% -$233K 0.01% 1303
2024
Q4
$22.3M Buy
+197,893
New +$23.2M 0.01% 1226

Other funds holding IVOG

Raymond James Financial's IVOG Position: Q1 2026 in Review

Raymond James Financial increased its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) stake by 6% in Q1 2026, buying an estimated $1.62M and bringing the position to 224,875 shares worth $28.1M. The position accounts for 0.01% of the portfolio, ranked #1232.

Raymond James Financial first reported a position in IVOG in Q4 2024 and has held it in 6 quarters since. 178 funds tracked by Wall St. Rank hold IVOG as of Q1 2026.

  • Raymond James Financial held 224,875 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $28.1M as of Q1 2026.
  • Raymond James Financial bought 12,682 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q1 2026, an estimated $1.62M.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1232 holding.
  • Raymond James Financial first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2024 and has held it in 6 quarters since.
  • 178 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.